Neogen Corporation Stock Repurchase Program, Number of Shares Authorized to be Repurchased
Neogen Corporation (NEOG) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 6.00 million shares as of 2018-10-31, per its 10-K filed 2022-07-27.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2022-07-27
- 2018-10-31: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 6.00M shares; Stock Repurchase Program, Number of Shares Authorized to be Repurchased as first filed 3.00M shares.
- 2008-12-31: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.50M shares; Stock Repurchase Program, Number of Shares Authorized to be Repurchased as first filed 750.00K shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased | Stock Repurchase Program, Number of Shares Authorized to be Repurchased as first filed |
|---|---|---|
| 2018-10-31 | 6.00M shares 10-K · filed 2022-07-27 | 3.00M shares 10-Q · filed 2018-12-28 |
| 2008-12-31 | 1.50M shares 10-Q · filed 2018-10-05 | 750.00K shares 10-Q · filed 2011-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |